Intestinal flora in the constipation patients before versus after lactulose intervention.

Medicine (Baltimore)

Department of Gastroenterology, Hua Dong Hospital, Fu Dan University, Shanghai, PR China.

Published: August 2023

This study aimed to investigate the characteristics of intestinal flora in patients with chronic functional constipation before and after lactulose intervention. Twenty-nine patients with constipation in the treatment group received oral lactulose (15 mL/d) for a month. Twenty healthy subjects served as controls. Stool specimens were collected before and after lactulose treatment. Fecal bacteria were examined by 16SrRNA gene sequencing and bioinformatics analysis. After lactulose treatment, most bacteria in the constipation group, including Bifidobacteria, Bacillus cereus, Prevotella, Bacillus, Anaerostipes, Oribacterium, and Mogibacterium increased as compared to those in the healthy control group. Anaerotruncus declined in the healthy control group after lactulose treatment. Our study shows lactulose can increase the abundance of probiotics, optimize the intestinal microenvironment, and alleviate constipation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419342PMC
http://dx.doi.org/10.1097/MD.0000000000034703DOI Listing

Publication Analysis

Top Keywords

lactulose treatment
12
intestinal flora
8
lactulose intervention
8
healthy control
8
control group
8
lactulose
7
constipation
5
flora constipation
4
constipation patients
4
patients versus
4

Similar Publications

A smart probe for detection of sugar markers for applications in gastrointestinal barrier dysfunction.

Biosens Bioelectron

December 2024

Bio-Acoustic MEMS in Medicine (BAMM) Laboratory, Canary Center at Stanford, Department of Radiology, Stanford School of Medicine, Stanford University, Palo Alto, CA, 94304, USA. Electronic address:

Article Synopsis
  • Gastrointestinal (GI) barrier dysfunction is a critical early indicator of multiple complex diseases, but current testing methods for saccharide molecules used to assess this function are expensive and time-consuming.
  • A new one-component system utilizing a naphthyl-pyridine core and boronic acid receptor has been developed for the early detection of saccharide biomarkers like lactulose, which indicates GI barrier issues.
  • The innovative design incorporates a scalable 96-well format with gold nanoparticles and combines plasmonics and fluorescence for sensitive lactulose quantification, aiming to create an affordable and portable diagnostic tool for routine GI permeability testing.
View Article and Find Full Text PDF

Relationship between Quality Practice Metrics and Treatment Outcomes in Hospitalized Cirrhotic Patients.

Asian Pac J Cancer Prev

December 2024

Division of Gastroenterology and Hepatology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University. 681 Samsen Road, Dusit District 10300, Bangkok, Thailand.

Background/aims: Variations in cirrhosis management practices and care quality affect patient prognoses and outcomes. We aimed to evaluate the number of successful cirrhosis care processes and the relationship between the quality statement implementation and clinical outcomes in patients with cirrhosis.

Methods: This retrospective cohort study included hospitalized patients with cirrhosis.

View Article and Find Full Text PDF

Introduction: Opioid-induced constipation (OIC) affects up to 90% of patients with cancer receiving long-term opioid-related analgesic therapy, resulting in various potential complications, compromised pain management and decreased quality of life. Laxatives stimulate or facilitate bowel evacuation. Traditional laxatives, such as polyethylene glycol and lactulose, are widely used because of their low cost, easy accessibility and tolerability.

View Article and Find Full Text PDF

Objective: The objective of this study is to compare the efficacy and safety of lubiprostone (Lub) with osmotic laxatives in the treatment of chronic idiopathic constipation (CIC).

Methods: A comprehensive literature search was conducted using PubMed, EMBASE, and the Cochrane Library in May 2024. Studies that met the inclusion criteria were manually searched by two independent reviewers.

View Article and Find Full Text PDF
Article Synopsis
  • Hyperammonemia, often caused by liver cirrhosis, is a key factor in encephalopathy cases, affecting patients' mental status.
  • Treatment typically involves lactulose and rifaximin to manage ammonia levels.
  • In a specific case, a patient with slightly elevated ammonia levels of 39 μmol/L recovered after 30 hours of fluid therapy, without the need for lactulose or rifaximin.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!